期刊文献+

GPC5过表达对人肺腺癌A549肿瘤起始细胞生物学功能的影响

Influence of over-expression of GPC5 on the biological function of human lung adenocaicinoma A549 cancer-initiating cells
下载PDF
导出
摘要 目的:探讨磷脂酰肌醇蛋白聚糖-5(glypican 5,GPC5)基因对人肺腺癌A549肿瘤起始细胞(cancer-initiating cells,CICs)生物学功能的影响。方法 :采用前期构建的过表达GPC5慢病毒载体稳定转染的细胞株GPC5-A549,无血清培养方法富集A549细胞中的CICs微球,通过定量分析检测微球大小,流式细胞术检测CD133阳性细胞比率,Matrigel和Tanswell小室检测细胞侵袭迁移能力,Western blot检测上皮细胞间质化相关蛋白表达。结果:与对照组相比,过表达GPC5后A549细胞中CICs微球形成数目明显减少,体积变小,CD133阳性率明显下降(P<0.05);细胞侵袭、迁移能力显著降低(P<0.05);E-cadherin的蛋白表达明显上调,Vimentin、N-cadherin的表达显著被抑制(P<0.05)。结论:GPC5过表达能够抑制肺腺癌细胞株A549中CICs的发生、侵袭和迁移,调控上皮细胞间质化相关蛋白表达。 Objective: To explore the effects of over-expression of GPC5 on the biological function of human lung adenocarcinoma A549 cancer-initiating cells(CICs). Methods: Lentivims-induced GPC5 over-expression was used for biological functional analyses in human lung adenocarcinoma A549 cell line, including cancer-initiating cell microspherescounting by light microscopy, CD133 positive cells measured by flow cytometry, migration and invasive activity detected by Matrigel and Transwell assay, as well as epithehal-mesenchymal transition-related protein expression detected by Western blot. Results: Compared with the control group, the numbers of cancer-initiating cell microspheres remarkly decreased(P〈0.05) and the percent of CDl33 positive cells was reduced(P〈0.05) in the GPC5 over-expressed group. The over-expression of GPC5 also inhibited the invasion and migration ability of CICs, and led to the down-regulation of Vimentin and N-cadherin, as well as the up-regulation of E-cadherin. Conclusion: The over-expression of GPC5 can inhibit the genesis, invasion and migration of human lung adenocarcinoma A549-CICs, and regulate the expression of EMT related proteins.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2015年第11期1528-1532,共5页 Journal of Nanjing Medical University(Natural Sciences)
基金 国家自然科学基金(81201830) 江苏省临床医学科技专项(BL2012030)
关键词 肺腺癌 磷脂酰肌醇蛋白聚糖-5 肿瘤起始细胞 上皮细胞间质化 lung adenocarcinoma glypican-5 cancer-initiating cells epithelial-mesenchymal transition
  • 相关文献

参考文献13

  • 1Yang X,Zhang Z,Qiu M,et al. Glypican-5 is a novel metastasis suppressor gene in non-small cell lung cancer [J]. Cancer Lett,2013,341(2):265-273.
  • 2Li Y,Yang P. GPC5 gene and its related pathways in lung cancer[J]. J Thorac 0ncol,2011,6(1) :2-5.
  • 3Qi J,Yu Y,Akilli Ozturk O,et al. New Wnt/beta-catenin target genes promote experimental metastasis and migra- tion of colorectal cancer cells through different signals[J/ OL]. Gut,2015, [2014-11-01]http://gut.bmj.com/con- tent/early/2015/07/08/gutjn1-2014-307900: Long. DOI:10.1136/gutjnl-2014-307900.
  • 4Bertolini G,D'Amico L,Moro M,et al. Microenvironment modulated metastatic CD133 ]/CXCR4 ]/EpCAM-lung cancer initiating cells sustain cancer dissemination and correlate with poor prognosis [ J ]. Cancer Res, 2015,75 (17) : 3636-3649.
  • 5Bertolini G,Roz L,Perego P,et al. Highly cancerigenic lung cancer CD133 ceils display stem-like features and are spared by cisplatin treatment[J]. Proc Nat Acad Sci USA, 2009,106(38) : 16281-16286.
  • 6Herpel E,Jensen K,Muley T,et al. The cancer stem cell antigens CD133,BCRP1/ABCG2 and CDll7/e-KIT are not associated with prognosis in resected early-stage non- small cell lung cancer [J]. Anticancer Res,2011,31 (12) :4491-4500.
  • 7Salnikov AV, Gladkich J, Moldenhauer G, et al. CD 133 is indicative for a resistance phenotype but does not repre- sent a prognostic marker for survival of non-small cell lung cancer patients[J]. Inter J Cancer,2010,126 (4): 950-958.
  • 8Battula VL,Evans KW,Hollier BG,et al. Epithelial-mes- enehymal transition-derived cells exhibit multilineage dif- ferentiation potential similar to mesenehymal stem cells [J]. Stem Cells,2010,28(8) : 1435-1445.
  • 9Suda K,Tomizawa K,Fujii M,et al. Epithelial to mes- enchymal transition in an epidermal growth factor recep- tor-mutant lung cancer cell line with acquired resistance to erlotinib[J]. J Thorac Oncol, 2011,6(7) : 1152-1161.
  • 10Nurwidya F,Takahashi F,Murakami A,et al. Acquired resistance of non-small cell lung cancer to epidermal growth factor receptor tyrosine kinase inhibitors [J]. Respir Investig, 2014,52 (2) : 82-91.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部